Lonza plots $935M in capacity upgrades in Europe and U.S., plans to add 550 jobs over next 3 years

Lonza plots $935M in capacity upgrades in Europe and U.S., plans to add 550 jobs over next 3 years

Source: 
Fierce Pharma
snippet: 

Even as COVID-19 manufacturing dominates headlines, Swiss CDMO juggernaut Lonza is taking steps to keep the rest of its production arsenal competitive. The company's latest move? A nearly $1 billion investment to boost capacity at sites in Europe and the U.S.